Human PBMC-NK Mouse Modeling Service for Immuno-Oncology Study
Creative Biolabs' Human PBMC-NK Mouse Model is designed to provide you with a powerful solution for evaluating the efficacy of your immuno-oncology candidates. We provide a platform for assessing therapeutic agents that leverage innate immunity, including NK cell engagers, monoclonal antibodies for ADCC, and a wide array of combination therapies. Creative Biolabs provides critical data on tumor growth inhibition, immune cell infiltration, and biomarker expression, enabling you to make informed decisions and advance your project with confidence.
IntroductionWhat We Can OfferWorkflowWhy Creative BiolabsCustomer ReviewsFAQsRelated ServicesContact Us
PBMC-NK Model: Advancing Immuno-Oncology Research
In the realm of immuno-oncology, the ability to accurately simulate human immune responses in vivo is critical for the development of innovative therapeutic strategies. The Human PBMC-NK Mouse Model stands as a pivotal tool, offering unparalleled insights into the functionality and efficacy of investigational drugs targeting natural killer (NK) cells. As a leading entity in the field, Creative Biolabs is at the forefront of employing this advanced model to transform immunotherapy research.
Fig.1 Applications of humanized mice in oncology. 1
What We Can Offer
At Creative Biolabs, we utilize the human PBMC-NK mouse model to provide a robust platform for immuno-oncology studies. This model supports a wide array of applications, from exploring the efficacy of novel immunotherapeutics to understanding the dynamics of immune checkpoint interactions and cytokine effects.
Seamless Integration with Patient-Derived Xenograft (PDX) Models
The model seamlessly integrates with patient derived xenograft (PDX) models, creating a comprehensive, highly predictive research environment. This integration is particularly beneficial for studying the interactions between tumor cells and the human immune system in a realistic context.
Our Human PBMC-NK Mouse Model for Immuno-Oncology Study
Highlights
Strategic Partnership
Engaging with Creative Biolabs establishes a strategic partnership committed to the successful realization of your project objectives, offering expert consultation and collaboration throughout the entire process, from initial study design to the final interpretation of experimental data.
Superior Predictive Capacity
The human PBMC-NK mouse model offers a highly predictive platform, designed to significantly minimize the translational discrepancy frequently observed in preclinical investigations, thereby effectively accelerating your therapeutic development pipeline.
Assurance of Data Reliability
We leverage profound scientific knowledge and an established history of performance to consistently generate reliable and actionable data, which provides investigators with substantiated confidence regarding their compound's performance profile in the in vivo setting.
Commitment to Quality and Rigor
Our institutional dedication to uncompromising quality and scientific rigor ensures that all studies are executed in strict adherence to the highest standards, consequently yielding robust and highly reproducible results essential for advancing your development program.
High Confidence
Using Creative Biolabs' human PBMC-NK mouse model for our research has significantly improved the predictive value of our in vivo studies, allowing us to confidently move our lead compound into the next phase. – J*n S***h
Enhanced Efficacy
The platform's ability to model ADCC accurately has facilitated a more precise understanding of our therapeutic agent's mechanism, which has been invaluable for optimizing its efficacy. – K**e B***n.
FAQs
Q: What makes the human PBMC-NK mouse model superior to traditional models?
A: The human PBMC-NK mouse model offers a more accurate depiction of human immune responses due to its high concentrations of mature human NK cells and a physiologically relevant CD16+ dominant composition. It also avoids the issue of NK cell depletion, providing more reliable results.
Q: How does the model integrate with PDX models?
A: The model integrates seamlessly with PDX models, creating a highly predictive research environment that is beneficial for studying the interactions between tumor cells and the human immune system.
Q: What are some of the key applications of this model?
A: Key applications include immunotherapy efficacy testing, immune checkpoint studies, and cytokine effect analysis, all of which contribute to a deeper understanding of immune modulation and therapeutic potential.
Related Services
Functional Checkpoint Analysis
Precisely determine the mechanism of action for your immunotherapeutic agents by leveraging our immune checkpoint functional assays. This suite of services targets both inhibitory and stimulatory checkpoint pathways for comprehensive analysis.
Employ our syngeneic mouse models to evaluate agents that require a fully intact, native murine immune system. This platform is essential for assessing complex immune mechanisms and potential immunotoxicity in vivo.
Through the human PBMC-NK mouse model, Creative Biolabs is pioneering advancements in immuno-oncology research, delivering transformative insights that pave the way for innovative therapeutic strategies. To learn more about how our human PBMC-NK mouse model can be tailored to your specific project needs and to receive a detailed quote, please contact our team.
Reference
Karnik, Isha et al. "Emerging Preclinical Applications of Humanized Mouse Models in the Discovery and Validation of Novel Immunotherapeutics and Their Mechanisms of Action for Improved Cancer Treatment." Pharmaceutics vol. 15,6 1600. 26 May. 2023. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/pharmaceutics15061600
Fig.1 Applications of humanized mice in oncology. 1
